* BioRestorative Therapies Inc BRTX.OQ reported a
quarterly
adjusted loss of 57 cents per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of $-1.19. The mean expectation of
two analysts for the quarter was for a loss of 69 cents per
share. Wall Street expected results to range from -73 cents
to -65 cents per share.
* Revenue rose 375% to $19.00 thousand from a year ago;
analysts
expected $15.00 thousand.
* BioRestorative Therapies Inc's reported EPS for the
quarter was
a loss of 57 cents.
* The company reported a quarterly loss of $2.83 million.
* BioRestorative Therapies Inc shares had held steady so far
this
quarter and lost 20.7% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 3% in
the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
* The average consensus recommendation for the biotechnology
&
medical research peer group is also "buy"
Wall Street's median 12-month price target for BioRestorative
Therapies Inc is $12.50
This summary was machine generated from LSEG data April 1 at
09:06 p.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2023 -0.69 -0.57 Beat
Sep. 30 2023 -0.68 -0.65 Beat
Jun. 30 2023 -1.19 -0.77 Beat
Mar. 31 2023 -1.26 -1.53 Missed